Vor Biopharma Inc.

NASDAQ: VOR · Real-Time Price · USD
2.08
0.10 (5.05%)
At close: Aug 15, 2025, 12:36 PM

Vor Biopharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
3.53M 3.49M 8.96M 4.45M
Gross Profit
-3.53M -3.49M -8.96M -4.45M
Operating Income
-121.19M -126.04M -93.42M -69.02M
Interest Income
4.27M 8.17M 1.32M 119K
Pretax Income
-116.91M -117.86M -92.09M -68.9M
Net Income
-116.91M -117.86M -90.77M -68.78M
Selling & General & Admin
27.88M 31.72M 28.87M 21.49M
Research & Development
93.31M 94.31M 64.55M 47.53M
Other Expenses
-3.53M -3.49M n/a n/a
Operating Expenses
117.66M 122.54M 93.42M 69.02M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
-121.19M 126.04M 93.42M 69.02M
Income Tax Expense
n/a n/a -1.32M -119K
Shares Outstanding (Basic)
68.71M 67.19M 39.55M 37.17M
Shares Outstanding (Diluted)
68.71M 67.19M 39.55M 37.17M
EPS (Basic)
-1.7 -1.75 -2.33 -1.89
EPS (Diluted)
-1.7 -1.75 -2.33 -1.89
EBITDA
-113.39M -114.37M -90.89M -67.58M
EBIT
-116.91M -117.86M -92.09M -68.9M
Depreciation & Amortization
3.53M 3.49M 2.52M 1.43M